Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tostrex in hypogonadal men with metabolic syndrome or type 2 diabetes
2005-002607-17Phase 3Completed
- Sponsor
- ProStrakan
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Itnogen in Hypoandrogenism (TD), sponsored by ProStrakan. Primary endpoints: Change in insulin resistance at 6 months and Change in insulin resistance at 2 years. Started Aug 2005; status: completed.
02
Drugs
Itnogen
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2005-002607-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002607-17.